Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety

Hepatocellular carcinoma (HCC) is a severe complication of advanced liver disease with a worldwide incidence of more than 600,000 patients per year. Liver function, clinical performance status, and tumor size are considered in the Barcelona Clinic Liver Cancer (BCLC) system. While curative treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Welker, Martin-Walter, Trojan, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804539/
https://www.ncbi.nlm.nih.gov/pubmed/24204170
http://dx.doi.org/10.2147/CMAR.S35029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804539/
https://www.ncbi.nlm.nih.gov/pubmed/24204170
http://dx.doi.org/10.2147/CMAR.S35029

Ejemplares similares